Announcement
Potential Sciences plans to train drug-discovery AI on simulated chemistry
Potential Sciences says its seed funding totals tens of millions of dollars, with backing from UK government fund SovAI.
TLDR
By simulating molecular interactions, Potential Sciences plans to build large datasets for training AI to identify targeted drug candidates. CEO Hatem Helal hopes the approach will cut experimentation costs and make rare-disease treatments more economical. Its ability to accurately predict drug-protein binding remains uncertain, and promising candidates would still need lengthy safety and efficacy testing.
Combined views
—
First seen ago
